RayThera
radiopharmaceutical platform combining novel isotopes with targeting ligands for cancer treatment
- Sector
- Biotech
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 22 pending · first 2025
- Rank in peer group#481 of 1449
Capital timeline
No federal awards or Form D filings are on record for this company.
Many early companies raise without filing a Form D, or have not yet won a federal award. New records appear here as the sources update.
Checked: SEC EDGAR Form D through Oct 23, 2026; SBIR and STTR awards through Oct 21, 2026; USAspending contract awards
Founder? Add funding contextStanding among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#481 · top 33%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 1 granted of 23- GrantedModulators Of Tnf Alpha Activity And Uses ThereofUSPTOUS 12,410,179
- PendingModulators Of Tnf Alpha Activity And Uses ThereofUSPTOApplication 19203856
- PendingSTAT6 Modulators And Methods Of Uses ThereofUSPTOApplication 63774384
Show all 23 patent records
- Modulators Of Tnf Alpha Activity And Uses ThereofSep 9, 2025 · US 12,410,179Granted
- Modulators Of Tnf Alpha Activity And Uses ThereofAug 21, 2025 · Application 19203856Pending
- STAT6 Modulators And Methods Of Uses ThereofApplication 63774384Pending
- STAT6 Modulators And Methods Of Uses ThereofApplication 63765019Pending
- STAT6 Modulators And Methods Of Uses ThereofApplication 63724224Pending
- JAK2 V617F Inhibitors And Methods Of Use ThereofApplication PCTUS2024056899Pending
- CCR4 Inhibitors And Methods Of Use ThereofApplication PCTUS2024050704Pending
- STAT6 Modulators And STAT6 Degraders And Methods Of Uses ThereofApplication 63694665Pending
- Modulators Of Tnf Alpha Activity And Uses ThereofApplication PCTUS2024042661Pending
- STAT6 Modulators And STAT6 Degraders And Methods Of Uses ThereofApplication 63673537Pending
- STAT6 Modulators And STAT6 Degraders And Methods Of Uses ThereofApplication 63662078Pending
- Modulators Of Tnf Alpha Activity And Uses ThereofApplication 63650626Pending
- CCR4 Inhibitors And Methods Of Use ThereofApplication 63642294Pending
- JAK2 V617F Inhibitors And Methods Of Use ThereofApplication 63639884Pending
- STAT6 Modulators And STAT6 Degraders And Methods Of Uses ThereofApplication 63636633Pending
- CCR4 Inhibitors And Methods Of Use ThereofApplication 63623743Pending
- Modulators Of Tnf Alpha Activity And Uses ThereofApplication 63613206Pending
- JAK2 V617F Inhibitors And Methods Of Use ThereofApplication 63602163Pending
- CCR4 Inhibitors And Methods Of Use ThereofApplication 63589480Pending
- Modulators Of Tnf Alpha Activity And Uses ThereofApplication 63519990Pending
- STAT6 Modulators And Methods Of Uses ThereofApplication PCTUS2025034193Pending
- Modulators Of Tnf Alpha Activity And Uses ThereofApplication 19510979Pending
- STAT6 Modulators And Methods Of Uses ThereofApplication PCTUS2025025338Pending
Related companies, and why
- FILAMENTECH. INC.Similar federal contract value in Biotech · null in contracts
- Magnet BiomedicineSimilar federal contract value in Biotech · null in contracts
- GENESEARCH, INC.Similar federal contract value in Biotech · null in contracts
- MORPHOGENESIS, INC.Similar federal contract value in Biotech · null in contracts
- MathNimbus IncSimilar federal contract value in Biotech · null in contracts
- INHIPROT, LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .